![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alzamend Neuro Inc | NASDAQ:ALZN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.061 | 1.64% | 3.791 | 3.78 | 3.99 | 4.09 | 3.52 | 3.75 | 18,326 | 16:25:59 |
1. Name and Address of Reporting Person * AULT MILTON C III | 2. Issuer Name and Ticker or Trading Symbol Alzamend Neuro, Inc. [ ALZN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/3/2021 | M(1) | 100000 | A | $0 | 250000 | D | |||
Common Stock | 6720388 | I | By Digital Power Lending, LLC (2) | |||||||
Common Stock | 15000000 | I | By Ault Life Sciences, Inc. (3) | |||||||
Common Stock | 10000000 | I | By Ault Life Sciences Fund, LLC (4) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options (Right to Buy) | $0.0004 | 11/3/2021 | M | 100000 | (5) | 4/29/2026 | Common Stock | 100000 | $0 | 2250000 | D | ||||
Call Option (right to buy) | $2.50 | 11/2/2021 | P | 50 | (6) | 5/20/2022 | Common Stock | 5000 | $79.5094 | 50 | I | By Digital Power Lending, LLC (2) | |||
Call Option (right to buy) | $2.50 | 11/3/2021 | P | 100 | (6) | 5/20/2022 | Common Stock | 10000 | $77.5094 | 150 | I | By Digital Power Lending, LLC (2) | |||
Call Option (right to buy) | $2.50 | (6) | 2/18/2022 | Common Stock | 40000 | 400 | I | By Digital Power Lending, LLC (2) | |||||||
Call Option (right to buy) | $2.50 | (6) | 2/18/2022 | Common Stock | 102000 | 1020 | I | By Digital Power Lending, LLC( (2) | |||||||
Call Option (right to buy) | $10.00 | (6) | 2/18/2022 | Common Stock | 40000 | 400 | I | By Digital Power Lending, LLC (2) | |||||||
Call Option (right to buy) | $7.50 | (6) | 2/18/2022 | Common Stock | 5000 | 50 | I | By Digital Power Lending, LLC (2) |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
AULT MILTON C III 3802 SPECTRUM BOULEVARD, SUITE 112C TAMPA, FL 33612 | X |
Signatures | ||
/s/ Milton C. Ault, III | 11/4/2021 | |
**Signature of Reporting Person | Date |
1 Year Alzamend Neuro Chart |
1 Month Alzamend Neuro Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions